Francis Knuettel

Mr. Francis P.
Knuettel is a Chief Financial Officer at OS Therapies, Inc., an Independent Director at Endovia Health Sciences, Inc., an Independent Director at Beeline Holdings, Inc., an Executive Chairman at Innovation1 Biotech, Inc. and a Chief Financial Officer at Oceantech Acquisitions I Corp.
He is on the Board of Directors at Endovia Health Sciences, Inc., Beeline Holdings, Inc., VisitIQ Corp., Etheros Pharmaceuticals Corp., ECOM Medical, Inc. and Colorado Outward Bound School.
Mr. Knuettel was previously employed as a President, CEO, CFO, Secretary & Director by Channel Therapeutics Corp., a Chief Financial Officer by Semper Paratus Acquisition Corp., a President, CEO, CFO, Secretary & Treasurer by Chromocell Therapeutics Corp., a Chief Financial Officer, Secretary & Treasurer by Pelthos Therapeutics, Inc., an Independent Director by Relativity Acquisition Corp., an Independent Director by Murphy Canyon Acquisition Corp., an Independent Director by ETHZilla Corp., a Chief Financial Officer by OCG, Inc. (Colorado), a Chief Financial Officer by MJardin Group, Inc., a Chief Financial Officer by Aqua Metals, Inc., a Chairman by Spindle, Inc., a Chief Financial Officer & Secretary by Marathon Digital Holdings, Inc., a Chief Financial Officer by Software Aspects, Inc., a Chief Financial Officer by InfoSearch Media, Inc., a Director, Chief Executive & Financial Officer by Internet Machines Corp., a Chief Financial & Operating Officer by Viking Systems, Inc., a Chief Financial Officer & Director-Finance by Fightertown Entertainment, Inc., a Chairman by Firepond, Inc., and a Managing Director & Chief Financial Officer by Greyhound IP LLC.
He also served on the board at Unrivaled Brands, Inc., Sanatio BioScience, Inc., Viridian Capital Advisors LLC, ETHZilla Corp.
and SCWorx Corp.
He received his undergraduate degree from Tufts University and an MBA from The Wharton School of the University of Pennsylvania.